HRT Financial LP trims Clearmind Medicine (CMND) stake with 22,139-share sale

Rhea-AI Filing Summary

HRT Financial LP, a ten percent owner of Clearmind Medicine Inc., reported an open‑market sale of 22,139 Class A Shares at $3.306 per share. After this transaction, HRT Financial LP directly holds 81,353 Class A Shares.

Insider Trade Summary

Net Seller: 22,139 shares ($73,192)

Net Sell 1 txn

Insider HRT FINANCIAL LP

Role null

Sold 22,139 shs ($73K)

Type	Security	Shares	Price	Value
Sale	Class A Shares	22,139	$3.306	$73K

Holdings After Transaction: Class A Shares — 81,353 shares (Direct, null)

Footnotes (1)

Key Figures

Shares sold: 22,139 shares Sale price: $3.306 per share Shares held after sale: 81,353 shares +1 more

4 metrics

Shares sold 22,139 shares Class A Shares sold in open-market transaction

Sale price $3.306 per share Price for the 22,139 Class A Shares sold

Shares held after sale 81,353 shares Direct Class A Share holdings post-transaction

Net share change -22,139 shares Net-sell direction in transaction summary

Key Terms

open-market sale, ten percent owner, Form 4, Class A Shares

4 terms

open-market sale financial

"transaction_action: "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

ten percent owner regulatory

"is_ten_percent_owner: 1"

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Class A Shares financial

"security_title: "Class A Shares""

Class A shares are one of a company’s distinct types of stock that come with a specific set of rights—commonly different voting power, dividend treatment, or transfer rules—defined in the company’s charter. Investors care because those rights affect control, income and resale value; like holding a seat at a table that has different rules or stronger chips than other seats, owning Class A changes how much influence and return you can expect.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

X

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

HRT FINANCIAL LP

(Last) (First) (Middle)

3 WORLD TRADE CENTER, 175 GREENWICH STRE

76TH FLOOR

(Street)

NEW YORK NEW YORK 10007

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Clearmind Medicine Inc. [ CMND ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Shares	06/16/2026		S		22,139	D	$3.306	81,353	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	Adam Nunes	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did HRT Financial LP report for CMND?

HRT Financial LP reported an open-market sale of 22,139 Class A Shares of Clearmind Medicine Inc. at $3.306 per share. This is a disclosed disposal of existing holdings, documented in a Form 4 insider trading report.

How many Clearmind Medicine (CMND) shares does HRT Financial LP hold after the sale?

After the reported transaction, HRT Financial LP directly holds 81,353 Class A Shares of Clearmind Medicine Inc. This figure reflects its position immediately following the 22,139-share open-market sale disclosed in the Form 4 filing.

Was the CMND insider transaction by HRT Financial LP a purchase or a sale?

The transaction was a sale. HRT Financial LP executed an open-market sale of 22,139 Class A Shares of Clearmind Medicine Inc. at a price of $3.306 per share, reducing its share count while remaining a significant holder.

What price did HRT Financial LP receive per CMND share in the reported sale?

HRT Financial LP sold the Clearmind Medicine Inc. Class A Shares at $3.306 per share. This transaction price applies to the 22,139 shares disclosed, providing a clear record of the valuation used in the reported open-market sale.

What does it mean that HRT Financial LP is a ten percent owner of CMND?

Being a ten percent owner means HRT Financial LP is classified as a significant shareholder of Clearmind Medicine Inc. Under SEC rules, such holders must report share transactions on Form 4, providing transparency into their buying and selling activity.